help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 21, 2006, doi:10.1165/rcmb.2006-0133OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0133OCv1
36/3/270    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Golan-Gerstl, R.
Right arrow Articles by Breuer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Golan-Gerstl, R.
Right arrow Articles by Breuer, R.
American Journal of Respiratory Cell and Molecular Biology. Vol. 36, pp. 270-275, 2007
© 2007 American Thoracic Society
DOI: 10.1165/rcmb.2006-0133OC

Epithelial Cell Apoptosis by Fas Ligand–Positive Myofibroblasts in Lung Fibrosis

Regina Golan-Gerstl, Shulamit B. Wallach-Dayan, Gail Amir and Raphael Breuer

Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, and Department of Pathology, Hadassah–Hebrew University Medical Center, Jerusalem, Israel; and Department of Pathology, Boston University School of Medicine, Boston, Massachusetts

Correspondence and requests for reprints should be addressed to Raphael Breuer, M.D., Institute of Pulmonary Medicine, Hadassah–Hebrew University Medical Center, P.O.B. 12,000, Jerusalem, Israel 91120. E-mail: raffi{at}hadassah.org.il

The Fas/Fas ligand (FasL) apoptotic pathway has been shown to be involved in bleomycin-induced lung fibrosis. We examined the hypothesis that myofibroblasts from fibrotic lungs possess a cytotoxic phenotype that causes apoptosis of epithelial cells via the Fas/FasL pathway. We show in vivo epithelial cell apoptosis and associated upregulation of Fas and apoptotic Fas pathway genes in epithelial cells of lungs with bleomycin-induced fibrosis. In addition, we show that FasL surface molecules are overexpressed on {alpha}-SMA–positive cells in mice with bleomycin-induced fibrosis, and in humans with idiopathic pulmonary fibrosis. This enables the molecules to kill Fas-positive epithelial cells. In contrast, FasL-deficient myofibroblasts lose this myofibroblast cytotoxic phenotype, both in vivo and in vitro. In vivo, there was no bleomycin-induced epithelial cell apoptosis, as assessed by specific M30 staining in chimeric FasL-deficient mice that lacked FasL-positive myofibroblasts. In vitro, FasL-positive, but not FasL-negative myofibroblasts, induce mouse lung epithelial cell apoptosis. Thus myofibroblast cytotoxicity may underlie the absence of re-epithelialization, resulting in persistent lung fibrosis.

Key Words: apoptosis • epithelial cell • Fas ligand • lung fibrosis • myofibroblast




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
F. Strutz
The great escape--myofibroblasts in fibrosis and the immune system
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2477 - 2479.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Wallach-Dayan, R. Golan-Gerstl, and R. Breuer
Evasion of myofibroblasts from immune surveillance: A mechanism for tissue fibrosis
PNAS, December 18, 2007; 104(51): 20460 - 20465.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Z. G. Fridlender, P. Y. Cohen, O. Golan, N. Arish, S. Wallach-Dayan, and R. Breuer
Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis
Eur. Respir. J., August 1, 2007; 30(2): 205 - 213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  ATS Best of the Web